Rank | Gene Set | Z-score |
---|---|---|
1 | L-amino acid import (GO:0043092) | 5.96789136 |
2 | cellular potassium ion homeostasis (GO:0030007) | 5.70819861 |
3 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.62207736 |
4 | amino acid import (GO:0043090) | 5.41421612 |
5 | sodium ion export (GO:0071436) | 5.41034893 |
6 | C4-dicarboxylate transport (GO:0015740) | 5.38134500 |
7 | cell communication by electrical coupling (GO:0010644) | 4.82851917 |
8 | alanine transport (GO:0032328) | 4.75049961 |
9 | gamma-aminobutyric acid transport (GO:0015812) | 4.53424140 |
10 | presynaptic membrane assembly (GO:0097105) | 4.47896950 |
11 | cellular sodium ion homeostasis (GO:0006883) | 4.42166745 |
12 | potassium ion import (GO:0010107) | 4.40125159 |
13 | negative regulation of astrocyte differentiation (GO:0048712) | 4.36066703 |
14 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.34493016 |
15 | presynaptic membrane organization (GO:0097090) | 4.29286455 |
16 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.24508491 |
17 | regulation of synaptic vesicle transport (GO:1902803) | 4.16505265 |
18 | locomotory exploration behavior (GO:0035641) | 4.16467159 |
19 | astrocyte differentiation (GO:0048708) | 4.13887939 |
20 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.06626463 |
21 | neuronal ion channel clustering (GO:0045161) | 4.05801411 |
22 | cerebellar granule cell differentiation (GO:0021707) | 3.99115097 |
23 | potassium ion homeostasis (GO:0055075) | 3.93956042 |
24 | central nervous system myelination (GO:0022010) | 3.91317790 |
25 | axon ensheathment in central nervous system (GO:0032291) | 3.91317790 |
26 | low-density lipoprotein particle remodeling (GO:0034374) | 3.89496497 |
27 | astrocyte development (GO:0014002) | 3.83195954 |
28 | atrial cardiac muscle cell action potential (GO:0086014) | 3.81826152 |
29 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.76142697 |
30 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.70448912 |
31 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.65729897 |
32 | neurotransmitter uptake (GO:0001504) | 3.64744826 |
33 | L-serine transport (GO:0015825) | 3.61616384 |
34 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.56392481 |
35 | positive regulation of synapse maturation (GO:0090129) | 3.54504073 |
36 | negative regulation of sodium ion transport (GO:0010766) | 3.53587487 |
37 | proline transport (GO:0015824) | 3.52783451 |
38 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.50986637 |
39 | glutamate receptor signaling pathway (GO:0007215) | 3.49372505 |
40 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.46179520 |
41 | response to auditory stimulus (GO:0010996) | 3.45782235 |
42 | membrane repolarization (GO:0086009) | 3.44016284 |
43 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.43605622 |
44 | neuromuscular process controlling balance (GO:0050885) | 3.43580088 |
45 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.36173359 |
46 | glutamate secretion (GO:0014047) | 3.35306257 |
47 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.29495627 |
48 | synaptic transmission, glutamatergic (GO:0035249) | 3.29481436 |
49 | vocalization behavior (GO:0071625) | 3.26584106 |
50 | regulation of neurotransmitter uptake (GO:0051580) | 3.25493670 |
51 | regulation of synaptic plasticity (GO:0048167) | 3.25101096 |
52 | neuronal action potential propagation (GO:0019227) | 3.21938717 |
53 | chondroitin sulfate catabolic process (GO:0030207) | 3.21443032 |
54 | acidic amino acid transport (GO:0015800) | 3.20366453 |
55 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.20079602 |
56 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.19514611 |
57 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.15724619 |
58 | prepulse inhibition (GO:0060134) | 3.14279726 |
59 | regulation of synapse structural plasticity (GO:0051823) | 3.12754105 |
60 | regulation of beta-amyloid formation (GO:1902003) | 3.12382206 |
61 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.12365714 |
62 | regulation of neurotransmitter transport (GO:0051588) | 3.11309075 |
63 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.10635836 |
64 | regulation of astrocyte differentiation (GO:0048710) | 3.10617959 |
65 | negative regulation of protein localization to cell surface (GO:2000009) | 3.10431296 |
66 | neuron cell-cell adhesion (GO:0007158) | 3.08909830 |
67 | regulation of ARF protein signal transduction (GO:0032012) | 3.08661984 |
68 | mechanosensory behavior (GO:0007638) | 3.08236283 |
69 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.07871101 |
70 | synaptic vesicle maturation (GO:0016188) | 3.07842450 |
71 | regulation of membrane repolarization (GO:0060306) | 3.07729076 |
72 | membrane assembly (GO:0071709) | 3.05216352 |
73 | myelination (GO:0042552) | 3.04764378 |
74 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.04083261 |
75 | glycine transport (GO:0015816) | 3.03937981 |
76 | regulation of neurotransmitter secretion (GO:0046928) | 3.03933591 |
77 | protein localization to synapse (GO:0035418) | 3.03806547 |
78 | adenine nucleotide transport (GO:0051503) | 3.03285099 |
79 | serine transport (GO:0032329) | 3.02852192 |
80 | positive regulation of dendritic spine development (GO:0060999) | 3.01473936 |
81 | ensheathment of neurons (GO:0007272) | 2.99731480 |
82 | axon ensheathment (GO:0008366) | 2.99731480 |
83 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.99636433 |
84 | auditory behavior (GO:0031223) | 2.99370031 |
85 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.98946163 |
86 | long-term memory (GO:0007616) | 2.97880498 |
87 | neurotransmitter secretion (GO:0007269) | 2.96487972 |
88 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.95021128 |
89 | positive regulation of membrane potential (GO:0045838) | 2.94335538 |
90 | membrane depolarization during action potential (GO:0086010) | 2.92578200 |
91 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.90739315 |
92 | myelination in peripheral nervous system (GO:0022011) | 2.90632563 |
93 | peripheral nervous system axon ensheathment (GO:0032292) | 2.90632563 |
94 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.90365278 |
95 | synaptic vesicle exocytosis (GO:0016079) | 2.89406590 |
96 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.88605807 |
97 | regulation of synapse maturation (GO:0090128) | 2.88449569 |
98 | cellular response to cholesterol (GO:0071397) | 2.87356082 |
99 | L-glutamate transport (GO:0015813) | 2.86176872 |
100 | positive regulation of potassium ion transport (GO:0043268) | 2.85640172 |
101 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.84911537 |
102 | vascular smooth muscle contraction (GO:0014829) | 2.84810480 |
103 | negative regulation of neurotransmitter transport (GO:0051589) | 2.84469811 |
104 | synaptic vesicle endocytosis (GO:0048488) | 2.84098695 |
105 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.83855798 |
106 | activation of protein kinase A activity (GO:0034199) | 2.83496873 |
107 | artery smooth muscle contraction (GO:0014824) | 2.82753998 |
108 | negative regulation of glial cell differentiation (GO:0045686) | 2.81952629 |
109 | layer formation in cerebral cortex (GO:0021819) | 2.81703673 |
110 | regulation of female receptivity (GO:0045924) | 2.81137608 |
111 | transmission of nerve impulse (GO:0019226) | 2.79862027 |
112 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.79146209 |
113 | postsynaptic membrane organization (GO:0001941) | 2.78126302 |
114 | neuroblast proliferation (GO:0007405) | 2.77303370 |
115 | regulation of postsynaptic membrane potential (GO:0060078) | 2.77092139 |
116 | regulation of synaptic transmission (GO:0050804) | 2.75623420 |
117 | regulation of respiratory system process (GO:0044065) | 2.74672802 |
118 | myelin maintenance (GO:0043217) | 2.74576991 |
119 | cGMP-mediated signaling (GO:0019934) | 2.74486547 |
120 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.74434766 |
121 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.73521670 |
122 | cerebellar Purkinje cell layer development (GO:0021680) | 2.73386941 |
123 | response to gravity (GO:0009629) | 2.73226471 |
124 | neuron-neuron synaptic transmission (GO:0007270) | 2.72723268 |
125 | neurotransmitter transport (GO:0006836) | 2.72357855 |
126 | ovulation cycle (GO:0042698) | 2.70859990 |
127 | sodium ion homeostasis (GO:0055078) | 2.70463633 |
128 | exploration behavior (GO:0035640) | 2.68341768 |
129 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.66767951 |
130 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.65587341 |
131 | cell communication involved in cardiac conduction (GO:0086065) | 2.61384686 |
132 | dermatan sulfate metabolic process (GO:0030205) | 2.60416500 |
133 | purine nucleotide transport (GO:0015865) | 2.59556155 |
134 | long-term synaptic potentiation (GO:0060291) | 2.59366521 |
135 | membrane repolarization during action potential (GO:0086011) | 2.59100300 |
136 | long term synaptic depression (GO:0060292) | 2.58212411 |
137 | cell differentiation in hindbrain (GO:0021533) | 2.56054229 |
138 | regulation of neurotransmitter levels (GO:0001505) | 2.55428690 |
139 | cellular response to sterol (GO:0036315) | 2.51894847 |
140 | dermatan sulfate biosynthetic process (GO:0030208) | 2.50635964 |
141 | lateral sprouting from an epithelium (GO:0060601) | 2.50567015 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.89220986 |
2 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.95025619 |
3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.76087460 |
4 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.71929016 |
5 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.54782828 |
6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.48361846 |
7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.46899008 |
8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.46899008 |
9 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.46423591 |
10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.35465928 |
11 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.34293907 |
12 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.33339265 |
13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.30753068 |
14 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.28894681 |
15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.17583503 |
16 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.16217142 |
17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.11289965 |
18 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.07491015 |
19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.01200109 |
20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.00814777 |
21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.99104861 |
22 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.88272273 |
23 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.81604150 |
24 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.80467926 |
25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.75480237 |
26 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.74891101 |
27 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.72855997 |
28 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.63416211 |
29 | RXR_22108803_ChIP-Seq_LS180_Human | 1.48634782 |
30 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.45265712 |
31 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.45048365 |
32 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.44833632 |
33 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.44615219 |
34 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.43961666 |
35 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.43901658 |
36 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.41846051 |
37 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.41687534 |
38 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.40508194 |
39 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.39029788 |
40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.38593920 |
41 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.38337407 |
42 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.37583279 |
43 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.35804889 |
44 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.35693228 |
45 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.34085359 |
46 | P300_19829295_ChIP-Seq_ESCs_Human | 1.32578348 |
47 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.30817802 |
48 | AR_25329375_ChIP-Seq_VCAP_Human | 1.29603017 |
49 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.28801860 |
50 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.28636052 |
51 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.27036542 |
52 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.23668858 |
53 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.20130049 |
54 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.19436674 |
55 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.19356019 |
56 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.19047937 |
57 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.18026688 |
58 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.17894798 |
59 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.17075729 |
60 | KDM2B_26808549_Chip-Seq_K562_Human | 1.16754781 |
61 | TP53_16413492_ChIP-PET_HCT116_Human | 1.15519993 |
62 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14088933 |
63 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.14070988 |
64 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.13759540 |
65 | AR_19668381_ChIP-Seq_PC3_Human | 1.13034860 |
66 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.12781171 |
67 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.12477941 |
68 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.12311512 |
69 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.12255456 |
70 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.11999604 |
71 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.11517009 |
72 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.10204824 |
73 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.10204824 |
74 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.09418646 |
75 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.08572777 |
76 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.08502404 |
77 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.07962718 |
78 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07116415 |
79 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.05886083 |
80 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.05042017 |
81 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.05021294 |
82 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.03011429 |
83 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03010041 |
84 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.02506921 |
85 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.02379867 |
86 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.02351952 |
87 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.02328100 |
88 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.01514794 |
89 | STAT3_23295773_ChIP-Seq_U87_Human | 1.01259009 |
90 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.00371445 |
91 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96607098 |
92 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95524386 |
93 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.95153286 |
94 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.94419268 |
95 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94419268 |
96 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.93149766 |
97 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.92706012 |
98 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.91723910 |
99 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.91429582 |
100 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91354626 |
101 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91273514 |
102 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.90963606 |
103 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.90105902 |
104 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.90079694 |
105 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.89504732 |
106 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.89351159 |
107 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.88867132 |
108 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.87624451 |
109 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.87310368 |
110 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86831301 |
111 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.85809884 |
112 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.85803544 |
113 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85532223 |
114 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.83393082 |
115 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.83138186 |
116 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.82257891 |
117 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.82166302 |
118 | TCF4_23295773_ChIP-Seq_U87_Human | 0.81691583 |
119 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.80903698 |
120 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.78082670 |
121 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.77125971 |
122 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.76940856 |
123 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.75382399 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 3.90301552 |
2 | MP0003136_yellow_coat_color | 3.83973770 |
3 | MP0005646_abnormal_pituitary_gland | 3.27893081 |
4 | * MP0003690_abnormal_glial_cell | 3.13767578 |
5 | MP0003635_abnormal_synaptic_transmissio | 2.85414968 |
6 | MP0009780_abnormal_chondrocyte_physiolo | 2.75573571 |
7 | MP0009046_muscle_twitch | 2.73282773 |
8 | MP0004885_abnormal_endolymph | 2.69642989 |
9 | MP0004858_abnormal_nervous_system | 2.67415831 |
10 | MP0004270_analgesia | 2.62156241 |
11 | MP0005423_abnormal_somatic_nervous | 2.50723766 |
12 | MP0001984_abnormal_olfaction | 2.44327325 |
13 | MP0001486_abnormal_startle_reflex | 2.43354916 |
14 | * MP0009745_abnormal_behavioral_response | 2.34401148 |
15 | MP0003329_amyloid_beta_deposits | 2.29105037 |
16 | MP0002822_catalepsy | 2.27928562 |
17 | MP0002064_seizures | 2.27102581 |
18 | MP0002063_abnormal_learning/memory/cond | 2.16663489 |
19 | MP0004043_abnormal_pH_regulation | 2.16171298 |
20 | MP0003880_abnormal_central_pattern | 2.08304485 |
21 | MP0001440_abnormal_grooming_behavior | 2.04707514 |
22 | MP0009384_cardiac_valve_regurgitation | 2.01756481 |
23 | MP0002572_abnormal_emotion/affect_behav | 1.97944608 |
24 | MP0003879_abnormal_hair_cell | 1.96248033 |
25 | MP0008569_lethality_at_weaning | 1.94758468 |
26 | MP0005670_abnormal_white_adipose | 1.92306426 |
27 | MP0002734_abnormal_mechanical_nocicepti | 1.91917022 |
28 | MP0002272_abnormal_nervous_system | 1.91780080 |
29 | MP0005171_absent_coat_pigmentation | 1.90816948 |
30 | MP0001485_abnormal_pinna_reflex | 1.86601776 |
31 | MP0001502_abnormal_circadian_rhythm | 1.76387463 |
32 | MP0005167_abnormal_blood-brain_barrier | 1.76289302 |
33 | MP0001501_abnormal_sleep_pattern | 1.73067606 |
34 | MP0003634_abnormal_glial_cell | 1.70590756 |
35 | * MP0003633_abnormal_nervous_system | 1.69154667 |
36 | MP0005394_taste/olfaction_phenotype | 1.67657385 |
37 | MP0005499_abnormal_olfactory_system | 1.67657385 |
38 | MP0005645_abnormal_hypothalamus_physiol | 1.61854446 |
39 | MP0001968_abnormal_touch/_nociception | 1.60424272 |
40 | MP0002067_abnormal_sensory_capabilities | 1.58773390 |
41 | MP0002254_reproductive_system_inflammat | 1.56721447 |
42 | MP0000778_abnormal_nervous_system | 1.54167198 |
43 | MP0002909_abnormal_adrenal_gland | 1.50800535 |
44 | MP0005386_behavior/neurological_phenoty | 1.44237935 |
45 | MP0004924_abnormal_behavior | 1.44237935 |
46 | MP0002557_abnormal_social/conspecific_i | 1.44149078 |
47 | MP0002736_abnormal_nociception_after | 1.41686127 |
48 | MP0008789_abnormal_olfactory_epithelium | 1.39881930 |
49 | MP0002733_abnormal_thermal_nociception | 1.33458155 |
50 | MP0000049_abnormal_middle_ear | 1.32006227 |
51 | MP0003279_aneurysm | 1.31647582 |
52 | * MP0003631_nervous_system_phenotype | 1.30707951 |
53 | MP0004742_abnormal_vestibular_system | 1.27929252 |
54 | MP0004142_abnormal_muscle_tone | 1.27460252 |
55 | MP0001970_abnormal_pain_threshold | 1.26858913 |
56 | MP0001986_abnormal_taste_sensitivity | 1.24358087 |
57 | MP0002089_abnormal_postnatal_growth/wei | 1.22040077 |
58 | MP0002882_abnormal_neuron_morphology | 1.16125312 |
59 | MP0006276_abnormal_autonomic_nervous | 1.14186211 |
60 | MP0000955_abnormal_spinal_cord | 1.13745411 |
61 | MP0000566_synostosis | 1.12957077 |
62 | MP0000920_abnormal_myelination | 1.12498248 |
63 | MP0003632_abnormal_nervous_system | 1.11285680 |
64 | MP0000604_amyloidosis | 1.09723118 |
65 | MP0001958_emphysema | 1.09675035 |
66 | MP0003137_abnormal_impulse_conducting | 1.08925491 |
67 | * MP0001963_abnormal_hearing_physiology | 1.08799814 |
68 | MP0002638_abnormal_pupillary_reflex | 1.08726651 |
69 | * MP0005551_abnormal_eye_electrophysiolog | 1.08340389 |
70 | MP0004215_abnormal_myocardial_fiber | 1.06546197 |
71 | MP0002735_abnormal_chemical_nociception | 1.02464612 |
72 | MP0002066_abnormal_motor_capabilities/c | 1.02061410 |
73 | MP0004130_abnormal_muscle_cell | 1.00976862 |
74 | MP0000026_abnormal_inner_ear | 0.99988944 |
75 | MP0003011_delayed_dark_adaptation | 0.98876873 |
76 | MP0003878_abnormal_ear_physiology | 0.98514881 |
77 | MP0005377_hearing/vestibular/ear_phenot | 0.98514881 |
78 | MP0002653_abnormal_ependyma_morphology | 0.97813048 |
79 | * MP0003075_altered_response_to | 0.95392446 |
80 | MP0002090_abnormal_vision | 0.95299728 |
81 | MP0002152_abnormal_brain_morphology | 0.94457713 |
82 | MP0000631_abnormal_neuroendocrine_gland | 0.94418613 |
83 | * MP0001905_abnormal_dopamine_level | 0.94114706 |
84 | MP0003938_abnormal_ear_development | 0.92741912 |
85 | MP0005388_respiratory_system_phenotype | 0.90587077 |
86 | MP0002133_abnormal_respiratory_system | 0.90587077 |
87 | MP0002229_neurodegeneration | 0.89668410 |
88 | MP0001299_abnormal_eye_distance/ | 0.86781273 |
89 | MP0008874_decreased_physiological_sensi | 0.86162734 |
90 | MP0002184_abnormal_innervation | 0.84682212 |
91 | MP0009379_abnormal_foot_pigmentation | 0.81251753 |
92 | MP0006072_abnormal_retinal_apoptosis | 0.80041760 |
93 | MP0000747_muscle_weakness | 0.75386393 |
94 | MP0003787_abnormal_imprinting | 0.74485085 |
95 | MP0004147_increased_porphyrin_level | 0.73964288 |
96 | MP0005409_darkened_coat_color | 0.73903949 |
97 | * MP0005253_abnormal_eye_physiology | 0.71695277 |
98 | MP0001177_atelectasis | 0.71435262 |
99 | MP0000751_myopathy | 0.71301326 |
100 | MP0005332_abnormal_amino_acid | 0.69412904 |
101 | MP0005595_abnormal_vascular_smooth | 0.69347884 |
102 | MP0004811_abnormal_neuron_physiology | 0.67248538 |
103 | MP0002752_abnormal_somatic_nervous | 0.66366912 |
104 | MP0005535_abnormal_body_temperature | 0.66192219 |
105 | MP0008872_abnormal_physiological_respon | 0.65880696 |
106 | MP0004134_abnormal_chest_morphology | 0.65828109 |
107 | MP0000749_muscle_degeneration | 0.65089996 |
108 | MP0000428_abnormal_craniofacial_morphol | 0.64853446 |
109 | MP0004782_abnormal_surfactant_physiolog | 0.63623282 |
110 | MP0002069_abnormal_eating/drinking_beha | 0.63578852 |
111 | MP0002332_abnormal_exercise_endurance | 0.63026732 |
112 | MP0001346_abnormal_lacrimal_gland | 0.61366450 |
113 | MP0001943_abnormal_respiration | 0.60938404 |
114 | MP0002233_abnormal_nose_morphology | 0.60363895 |
115 | MP0001529_abnormal_vocalization | 0.60224511 |
116 | MP0001270_distended_abdomen | 0.59567652 |
117 | MP0000579_abnormal_nail_morphology | 0.57803719 |
118 | MP0005165_increased_susceptibility_to | 0.56796212 |
119 | MP0002249_abnormal_larynx_morphology | 0.55403667 |
120 | MP0004036_abnormal_muscle_relaxation | 0.54899213 |
121 | MP0000569_abnormal_digit_pigmentation | 0.54733285 |
122 | MP0010769_abnormal_survival | 0.51496045 |
123 | MP0003045_fibrosis | 0.50069888 |
124 | MP0000462_abnormal_digestive_system | 0.49502248 |
125 | MP0010768_mortality/aging | 0.47721768 |
126 | MP0005623_abnormal_meninges_morphology | 0.47612737 |
127 | MP0004085_abnormal_heartbeat | 0.46967237 |
128 | MP0002082_postnatal_lethality | 0.46100286 |
129 | MP0010770_preweaning_lethality | 0.46100286 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Aplasia involving bones of the extremities (HP:0009825) | 6.43185107 |
2 | Aplasia involving bones of the upper limbs (HP:0009823) | 6.43185107 |
3 | Aplasia of the phalanges of the hand (HP:0009802) | 6.43185107 |
4 | Focal motor seizures (HP:0011153) | 4.75772814 |
5 | Megalencephaly (HP:0001355) | 4.41966644 |
6 | Synostosis involving the elbow (HP:0003938) | 4.24120485 |
7 | Humeroradial synostosis (HP:0003041) | 4.24120485 |
8 | Atonic seizures (HP:0010819) | 3.98185137 |
9 | Hemiparesis (HP:0001269) | 3.94697382 |
10 | Ankle clonus (HP:0011448) | 3.93951777 |
11 | Abnormality of binocular vision (HP:0011514) | 3.89640117 |
12 | Diplopia (HP:0000651) | 3.89640117 |
13 | Obstructive sleep apnea (HP:0002870) | 3.69934163 |
14 | Abnormality of the middle phalanges of the toes (HP:0010183) | 3.43297580 |
15 | Hemiplegia (HP:0002301) | 3.41889529 |
16 | Potter facies (HP:0002009) | 3.34115337 |
17 | Facial shape deformation (HP:0011334) | 3.34115337 |
18 | Spastic gait (HP:0002064) | 3.27067668 |
19 | Myokymia (HP:0002411) | 3.26507968 |
20 | Long nose (HP:0003189) | 3.22933691 |
21 | Short hallux (HP:0010109) | 3.19725742 |
22 | Neurofibrillary tangles (HP:0002185) | 3.16600188 |
23 | Hypoplastic left heart (HP:0004383) | 3.15289095 |
24 | Progressive cerebellar ataxia (HP:0002073) | 3.13913751 |
25 | Alopecia of scalp (HP:0002293) | 3.12075590 |
26 | Action tremor (HP:0002345) | 3.07576009 |
27 | Epileptic encephalopathy (HP:0200134) | 3.06567781 |
28 | Focal seizures (HP:0007359) | 3.01955898 |
29 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.96488353 |
30 | Papilledema (HP:0001085) | 2.93759988 |
31 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.88038264 |
32 | Mixed hearing impairment (HP:0000410) | 2.78824950 |
33 | Mutism (HP:0002300) | 2.78436183 |
34 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 2.69097627 |
35 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 2.68981335 |
36 | Short middle phalanx of the 5th finger (HP:0004220) | 2.67916834 |
37 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.67015979 |
38 | Visual hallucinations (HP:0002367) | 2.64774685 |
39 | Insomnia (HP:0100785) | 2.63025821 |
40 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.61630772 |
41 | Dysdiadochokinesis (HP:0002075) | 2.60073523 |
42 | Akinesia (HP:0002304) | 2.58217902 |
43 | Metabolic alkalosis (HP:0200114) | 2.55771585 |
44 | Lower limb muscle weakness (HP:0007340) | 2.53254133 |
45 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.51802344 |
46 | Torticollis (HP:0000473) | 2.51715175 |
47 | Neuronal loss in central nervous system (HP:0002529) | 2.51083493 |
48 | Abnormality of the corticospinal tract (HP:0002492) | 2.49881531 |
49 | Follicular hyperkeratosis (HP:0007502) | 2.49043348 |
50 | Bronchomalacia (HP:0002780) | 2.47831326 |
51 | Abnormal ciliary motility (HP:0012262) | 2.45193459 |
52 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.43626522 |
53 | Increased circulating renin level (HP:0000848) | 2.41924526 |
54 | Hyporeflexia of lower limbs (HP:0002600) | 2.41539364 |
55 | Fibular aplasia (HP:0002990) | 2.40411324 |
56 | Generalized tonic-clonic seizures (HP:0002069) | 2.40157378 |
57 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 2.39288667 |
58 | Anxiety (HP:0000739) | 2.37077149 |
59 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.36760491 |
60 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.36760491 |
61 | Split foot (HP:0001839) | 2.36751643 |
62 | Sleep apnea (HP:0010535) | 2.36193075 |
63 | Bundle branch block (HP:0011710) | 2.35807329 |
64 | Rapidly progressive (HP:0003678) | 2.34974256 |
65 | Cerebral inclusion bodies (HP:0100314) | 2.34708189 |
66 | Abnormal eating behavior (HP:0100738) | 2.33950659 |
67 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.33265510 |
68 | Supranuclear gaze palsy (HP:0000605) | 2.32987899 |
69 | Limb dystonia (HP:0002451) | 2.31255582 |
70 | Rigidity (HP:0002063) | 2.30930754 |
71 | Cerebral hypomyelination (HP:0006808) | 2.30854761 |
72 | Urinary urgency (HP:0000012) | 2.30240592 |
73 | Hypoplastic heart (HP:0001961) | 2.29782138 |
74 | Narrow nasal bridge (HP:0000446) | 2.28973755 |
75 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.28798714 |
76 | Confusion (HP:0001289) | 2.27837258 |
77 | Abnormality of the nasal septum (HP:0000419) | 2.25289804 |
78 | Poor eye contact (HP:0000817) | 2.24914048 |
79 | Bradykinesia (HP:0002067) | 2.24511108 |
80 | Intention tremor (HP:0002080) | 2.24178816 |
81 | Fetal akinesia sequence (HP:0001989) | 2.23754244 |
82 | Abnormality of the dental pulp (HP:0006479) | 2.23716699 |
83 | Status epilepticus (HP:0002133) | 2.21757394 |
84 | Abnormal urine output (HP:0012590) | 2.21255330 |
85 | Abnormal drinking behavior (HP:0030082) | 2.20510260 |
86 | Polydipsia (HP:0001959) | 2.20510260 |
87 | Alacrima (HP:0000522) | 2.19804992 |
88 | Dialeptic seizures (HP:0011146) | 2.13765086 |
89 | Abnormality of secondary sexual hair (HP:0009888) | 2.12153407 |
90 | Abnormality of the axillary hair (HP:0100134) | 2.12153407 |
91 | Annular pancreas (HP:0001734) | 2.09607292 |
92 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.09096382 |
93 | Turricephaly (HP:0000262) | 2.08810407 |
94 | Spastic tetraparesis (HP:0001285) | 2.08802628 |
95 | Postural instability (HP:0002172) | 2.08187041 |
96 | Clonus (HP:0002169) | 2.07892869 |
97 | Thickened helices (HP:0000391) | 2.07066136 |
98 | Scanning speech (HP:0002168) | 2.05975286 |
99 | Hyperventilation (HP:0002883) | 2.05659927 |
100 | Abnormality of permanent molar morphology (HP:0011071) | 2.05339812 |
101 | Abnormality of the dental root (HP:0006486) | 2.05339812 |
102 | Taurodontia (HP:0000679) | 2.05339812 |
103 | Foot dorsiflexor weakness (HP:0009027) | 2.04104847 |
104 | Abnormality of the periventricular white matter (HP:0002518) | 2.03864815 |
105 | Truncal ataxia (HP:0002078) | 2.02141396 |
106 | Median cleft lip (HP:0000161) | 2.02114835 |
107 | Anomalous pulmonary venous return (HP:0010772) | 2.01419237 |
108 | Abnormality of renal excretion (HP:0011036) | 2.01380074 |
109 | Epileptiform EEG discharges (HP:0011182) | 1.99528888 |
110 | Pheochromocytoma (HP:0002666) | 1.99340890 |
111 | Cutaneous syndactyly (HP:0012725) | 1.99196122 |
112 | Abnormal social behavior (HP:0012433) | 1.97693826 |
113 | Impaired social interactions (HP:0000735) | 1.97693826 |
114 | Bowel incontinence (HP:0002607) | 1.94746795 |
115 | Heart block (HP:0012722) | 1.94566402 |
116 | Apathy (HP:0000741) | 1.92591060 |
117 | Abnormality of chromosome segregation (HP:0002916) | 1.92546895 |
118 | Abnormality of the foot musculature (HP:0001436) | 1.91197078 |
119 | Neuroendocrine neoplasm (HP:0100634) | 1.91103328 |
120 | Clumsiness (HP:0002312) | 1.91072120 |
121 | Choreoathetosis (HP:0001266) | 1.90659613 |
122 | Muscle fiber splitting (HP:0003555) | 1.90396095 |
123 | Abnormality of molar morphology (HP:0011070) | 1.90065515 |
124 | Abnormality of molar (HP:0011077) | 1.90065515 |
125 | Stereotypic behavior (HP:0000733) | 1.89590458 |
126 | Atrioventricular block (HP:0001678) | 1.89554866 |
127 | Focal dystonia (HP:0004373) | 1.89141966 |
128 | Abnormality of the middle phalanges of the hand (HP:0009833) | 1.89101657 |
129 | Overriding aorta (HP:0002623) | 1.88910212 |
130 | Paraparesis (HP:0002385) | 1.88906623 |
131 | Delusions (HP:0000746) | 1.88625879 |
132 | Peripheral hypomyelination (HP:0007182) | 1.88215103 |
133 | Postural tremor (HP:0002174) | 1.88194768 |
134 | Absence seizures (HP:0002121) | 1.88071701 |
135 | Morphological abnormality of the middle ear (HP:0008609) | 1.87735629 |
136 | Craniofacial dystonia (HP:0012179) | 1.81847556 |
137 | Hypokalemic alkalosis (HP:0001949) | 1.81697905 |
138 | Increased CSF protein (HP:0002922) | 1.81062770 |
139 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.80942110 |
140 | Tetraparesis (HP:0002273) | 1.80296763 |
141 | Tetraplegia (HP:0002445) | 1.79875471 |
142 | Abnormality of the pulmonary veins (HP:0011718) | 1.78514725 |
143 | Polyuria (HP:0000103) | 1.76304347 |
144 | Dysmetria (HP:0001310) | 1.76232211 |
145 | Hammertoe (HP:0001765) | 1.75722511 |
146 | Myotonia (HP:0002486) | 1.75622954 |
147 | Abnormal atrioventricular conduction (HP:0005150) | 1.75264156 |
148 | Abnormal large intestine physiology (HP:0012700) | 1.74365610 |
149 | Maternal diabetes (HP:0009800) | 1.73806735 |
150 | Blue irides (HP:0000635) | 1.72524379 |
151 | Aqueductal stenosis (HP:0002410) | 1.72316526 |
152 | Abnormality of cochlea (HP:0000375) | 1.71773891 |
153 | Morphological abnormality of the inner ear (HP:0011390) | 1.70538263 |
154 | Depression (HP:0000716) | 1.69371342 |
155 | Tarsal synostosis (HP:0008368) | 1.67797069 |
156 | Renal tubular acidosis (HP:0001947) | 1.67483220 |
157 | Absent/shortened dynein arms (HP:0200106) | 1.67302105 |
158 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.67302105 |
159 | Febrile seizures (HP:0002373) | 1.67226392 |
160 | Gaze-evoked nystagmus (HP:0000640) | 1.66600368 |
Rank | Gene Set | Z-score |
---|---|---|
1 | LMTK2 | 4.28116809 |
2 | TNIK | 3.42018803 |
3 | NTRK2 | 3.24143840 |
4 | PHKG2 | 2.84903346 |
5 | PHKG1 | 2.84903346 |
6 | NTRK3 | 2.70774888 |
7 | EPHA4 | 2.62590809 |
8 | CASK | 2.31116678 |
9 | PRKD3 | 2.30122331 |
10 | MARK1 | 2.06971035 |
11 | SGK2 | 1.92474746 |
12 | PINK1 | 1.87321387 |
13 | MINK1 | 1.84914292 |
14 | SGK494 | 1.80284188 |
15 | SGK223 | 1.80284188 |
16 | MAP2K7 | 1.77444726 |
17 | MAP3K4 | 1.70564335 |
18 | SGK3 | 1.52402960 |
19 | PAK6 | 1.49609458 |
20 | NEK6 | 1.48692579 |
21 | KSR2 | 1.42382817 |
22 | MAP3K9 | 1.41512681 |
23 | MAPK13 | 1.34797478 |
24 | WNK1 | 1.32965371 |
25 | PRKCG | 1.31795087 |
26 | CAMKK1 | 1.31535854 |
27 | MUSK | 1.31146068 |
28 | PAK3 | 1.21233421 |
29 | MAPK12 | 1.19802109 |
30 | STK38 | 1.19722953 |
31 | CDK5 | 1.18809377 |
32 | MAP3K13 | 1.17589064 |
33 | CDC42BPA | 1.16844992 |
34 | DAPK2 | 1.16696415 |
35 | LATS2 | 1.16608692 |
36 | ROCK2 | 1.15887204 |
37 | NTRK1 | 1.15124506 |
38 | MAP2K4 | 1.08142838 |
39 | OXSR1 | 1.04103122 |
40 | ARAF | 1.03830593 |
41 | FGFR2 | 1.03451968 |
42 | PRKCE | 1.01212428 |
43 | RIPK1 | 0.96214542 |
44 | MARK2 | 0.96188754 |
45 | MST4 | 0.94366939 |
46 | SIK1 | 0.94030567 |
47 | CAMK2G | 0.92870467 |
48 | SGK1 | 0.92596024 |
49 | MAP3K2 | 0.92511920 |
50 | CAMK2A | 0.91946936 |
51 | ROCK1 | 0.90814956 |
52 | INSRR | 0.90764197 |
53 | CAMKK2 | 0.88394147 |
54 | ERBB3 | 0.86977343 |
55 | PDGFRA | 0.86118386 |
56 | MAPK7 | 0.85792720 |
57 | TYRO3 | 0.84933830 |
58 | CAMK2B | 0.84415933 |
59 | PRKCH | 0.81814226 |
60 | TNK2 | 0.79951806 |
61 | PIK3CA | 0.77042268 |
62 | RET | 0.75851786 |
63 | CAMK2D | 0.74093781 |
64 | TRIB3 | 0.73081036 |
65 | DYRK1A | 0.71995338 |
66 | FES | 0.70617896 |
67 | STK24 | 0.70554284 |
68 | ERBB4 | 0.67326832 |
69 | MAP3K7 | 0.66912574 |
70 | PLK2 | 0.66876900 |
71 | CDK18 | 0.65878185 |
72 | ERBB2 | 0.65070396 |
73 | MAPK15 | 0.64391503 |
74 | STK38L | 0.63124956 |
75 | CSNK1A1 | 0.62394126 |
76 | BMX | 0.60712788 |
77 | CDK11A | 0.60507516 |
78 | GRK5 | 0.59414576 |
79 | CDK14 | 0.58959040 |
80 | PDGFRB | 0.58934846 |
81 | DAPK1 | 0.58881501 |
82 | MAPKAPK5 | 0.58584806 |
83 | PRKG1 | 0.57857276 |
84 | DMPK | 0.56813089 |
85 | WNK3 | 0.56434723 |
86 | CAMK4 | 0.55531362 |
87 | MAP3K12 | 0.55389962 |
88 | JAK2 | 0.55118123 |
89 | ADRBK1 | 0.55001626 |
90 | PDPK1 | 0.54731635 |
91 | PRPF4B | 0.53268975 |
92 | * PRKCA | 0.52564081 |
93 | JAK1 | 0.52403461 |
94 | UHMK1 | 0.52119431 |
95 | CSNK1G2 | 0.51868622 |
96 | MAPK4 | 0.51699537 |
97 | STK39 | 0.51232595 |
98 | PRKD1 | 0.50867399 |
99 | FGFR3 | 0.50678227 |
100 | MAPK10 | 0.50542997 |
101 | KSR1 | 0.50434398 |
102 | OBSCN | 0.49765232 |
103 | CCNB1 | 0.49100107 |
104 | RPS6KA3 | 0.49055161 |
105 | PRKACA | 0.48540488 |
106 | ALK | 0.47380327 |
107 | FGFR1 | 0.47038154 |
108 | PRKACG | 0.46065568 |
109 | CAMK1 | 0.45363800 |
110 | STK11 | 0.44767445 |
111 | SIK2 | 0.44620466 |
112 | RAF1 | 0.44138034 |
113 | CDK19 | 0.44057923 |
114 | FYN | 0.43815304 |
115 | IGF1R | 0.43498870 |
116 | SRC | 0.43403025 |
117 | PTK6 | 0.42856646 |
118 | RIPK4 | 0.42486012 |
119 | FER | 0.42405887 |
120 | FGR | 0.42306314 |
121 | PDK1 | 0.42075711 |
122 | PRKCZ | 0.41545957 |
123 | CDK15 | 0.40796738 |
124 | PKN1 | 0.40164245 |
125 | PNCK | 0.39383235 |
126 | BMPR2 | 0.34861100 |
127 | LIMK1 | 0.34581129 |
128 | CSNK1D | 0.34435506 |
129 | MAP2K1 | 0.34063341 |
130 | RPS6KB1 | 0.33295620 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 5.69512882 |
2 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.77971131 |
3 | Nicotine addiction_Homo sapiens_hsa05033 | 3.04507205 |
4 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.61323592 |
5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.36593967 |
6 | Salivary secretion_Homo sapiens_hsa04970 | 2.19481961 |
7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.17169856 |
8 | Gastric acid secretion_Homo sapiens_hsa04971 | 2.11995829 |
9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.82575806 |
10 | Circadian entrainment_Homo sapiens_hsa04713 | 1.80816782 |
11 | Insulin secretion_Homo sapiens_hsa04911 | 1.77347781 |
12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.67492780 |
13 | Morphine addiction_Homo sapiens_hsa05032 | 1.66207485 |
14 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.50212193 |
15 | Long-term potentiation_Homo sapiens_hsa04720 | 1.44211200 |
16 | Olfactory transduction_Homo sapiens_hsa04740 | 1.43607779 |
17 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.42410880 |
18 | * Bile secretion_Homo sapiens_hsa04976 | 1.42102766 |
19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.33465883 |
20 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.33222487 |
21 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.32757307 |
22 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.31705192 |
23 | Taste transduction_Homo sapiens_hsa04742 | 1.31608218 |
24 | Renin secretion_Homo sapiens_hsa04924 | 1.26526529 |
25 | Mineral absorption_Homo sapiens_hsa04978 | 1.22341724 |
26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.19034951 |
27 | Cocaine addiction_Homo sapiens_hsa05030 | 1.17682837 |
28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.17591391 |
29 | Prion diseases_Homo sapiens_hsa05020 | 1.16683500 |
30 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.16503598 |
31 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.14183109 |
32 | Long-term depression_Homo sapiens_hsa04730 | 1.11704288 |
33 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.10707316 |
34 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.09331786 |
35 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.08596608 |
36 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.04175332 |
37 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.02661331 |
38 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.99993843 |
39 | Circadian rhythm_Homo sapiens_hsa04710 | 0.99954647 |
40 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.99368922 |
41 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.96844080 |
42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.95547468 |
43 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.94991117 |
44 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.93203195 |
45 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.91745771 |
46 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.90803403 |
47 | Gap junction_Homo sapiens_hsa04540 | 0.88532222 |
48 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.88303025 |
49 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.88188283 |
50 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.87904915 |
51 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.87107127 |
52 | Melanogenesis_Homo sapiens_hsa04916 | 0.82293718 |
53 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.78365801 |
54 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.77157764 |
55 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.76522789 |
56 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.76014772 |
57 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.75459117 |
58 | * Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.75343168 |
59 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.73723375 |
60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.72599039 |
61 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.71535694 |
62 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.71374743 |
63 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.70395053 |
64 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.69920387 |
65 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.69341962 |
66 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.68610982 |
67 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.67553603 |
68 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.66420756 |
69 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.65498021 |
70 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.64290117 |
71 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.63944050 |
72 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.63457354 |
73 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.61697616 |
74 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.59490227 |
75 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.59392382 |
76 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.58872313 |
77 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.58830561 |
78 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.58098182 |
79 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.58051416 |
80 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.57851316 |
81 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56256833 |
82 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.55588515 |
83 | Endometrial cancer_Homo sapiens_hsa05213 | 0.54697324 |
84 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.53920848 |
85 | Axon guidance_Homo sapiens_hsa04360 | 0.53905561 |
86 | Endocytosis_Homo sapiens_hsa04144 | 0.53341398 |
87 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.53310856 |
88 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.52434420 |
89 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.51886763 |
90 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.51346718 |
91 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.49921614 |
92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49135267 |
93 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.48823209 |
94 | Tight junction_Homo sapiens_hsa04530 | 0.47462532 |
95 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47360480 |
96 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.45150275 |
97 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.42899694 |
98 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.40371871 |
99 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.40256928 |
100 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.39031064 |
101 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.38695083 |
102 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.37975687 |
103 | ABC transporters_Homo sapiens_hsa02010 | 0.37680510 |
104 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.36129725 |
105 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.35379641 |
106 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.34875081 |
107 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.34577450 |
108 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.34056814 |
109 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.33732505 |
110 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.32478822 |
111 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.31986965 |
112 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.31965530 |
113 | Peroxisome_Homo sapiens_hsa04146 | 0.31829322 |
114 | Glioma_Homo sapiens_hsa05214 | 0.31312148 |
115 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.31170972 |
116 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.31157015 |
117 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.31022841 |
118 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.30967430 |
119 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.29950493 |
120 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.29024960 |
121 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.28814535 |
122 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.28662137 |
123 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.28327777 |
124 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.27868829 |
125 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.27793364 |
126 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.25040441 |
127 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.22069604 |